The approach of Dr. Sherley and Asymmetrex to estimate the numbers of adult stem cells in tissue is highly innovative…
Recent Posts
-
Asymmetrex Introduces Therapeutic Stem Cell Dosage Technologies to Biotherapeutics Bioprocessing Companies
-
Asymmetrex Discusses a Near Horizon for Stem Cell Dosage in Stem Cell Therapy and Gene Therapy Clinical Trial Supply Chains
-
Asymmetrex Will Discuss the Impact of Its Technology for Dosing Therapeutic Stem Cells
-
Asymmetrex Describes How New Technologies for Quantifying Stem Cell Dosage Will Improve the Effectiveness of the Stem Cell Clinical Trial Supply Chain
-
Asymmetrex Stem Cell Strains for Immortal DNA Strand Research Featured by Kerafast
